Genmab A/S

GMABNasdaq Denmark Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.709 B

$36.65 -3.04%

Close of 8 Oct 2026

As of 8 Oct 2026, Genmab A/S (GMAB) has a market capitalization of $4.71B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#54ErascaERAS$4.94B
#55Dianthus TherapeuticsDNTH$4.75B
#56Genmab A/SGMAB$4.71B
#57VeradermicsMANE$4.64B
#58Edgewise TherapeuticsEWTX$4.30B

What if Genmab A/S were worth as much as…

Open the what-if tool →

Gold $29.0T

$225,682.76

Per share 6,158× higher

Bitcoin $1.65T

$12,819.66

Per share 350× higher

Nvidia $5.72T

$44,545.21

Per share 1,215× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Genmab A/S are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Oct 2026. Read the methodology.